UCSF Limited Submission Opportunities
(Applications through UCSF Limited Submission Program)
- Internal Deadline: July 6, 2026
Rita Allen Scholars
This program funds basic biomedical research in the fields of cancer, immunology, and neuroscience. It embraces innovative research with above-average risk and groundbreaking possibilities. - Internal Deadline: July 16, 2026
NIH Director’s Early Independence Award (DP5 Clinical Trial Optional)
This award helps exceptional new scientists start independent research careers right after finishing their doctoral degree or clinical training, forgoing postdoctoral training. It is intended for early-stage investigators who have a record of scientific innovation and research productivity and have demonstrated unusual scientific vision and maturity. - Extended Deadline: July 28, 2026
Susan G. Komen Foundation Career Catalyst Research Grant
This program fosters promising breast cancer researchers who are in the early stages of their faculty careers by providing support for up to three years of protected time for research career development under the guidance of a Mentor Committee. -
Internal Deadline: Aug 6, 2026
Gabrielle's Angel Foundation Medical Research Awards
This program supports promising independent early-career investigators by funding innovative, translational proposals in blood cancer research.
Intramural Funding Opportunities
For questions about intramural awards, please contact Meredith Donnelly.
- Deadline: July 31, 2026
UCSF Brain Tumor SPORE Development Research Program (DRP) Awards
A component of the UCSF Brain Tumor SPORE, the Developmental Research Program (DRP) offers funds to both new and established investigators to initiate translationally oriented research projects that have the potential to impact the diagnosis or therapy of human brain tumors. - Deadline: July 31, 2026
UCSF Brain Tumor SPORE Career Enhancement Program (CEP) Awards
A component of the UCSF Brain Tumor SPORE, the Career Enhancement Program (CEP) aims to attract outstanding basic scientists and clinical investigators to the field of brain tumor research, to assist in the career development of junior faculty in the basic and clinical sciences, and to encourage collaborations between investigators which can lead to new ideas and directions in brain tumor research and can contribute to career development. - Deadline: Oct 26, 2026
UCSF Prostate Cancer Program Pilot Awards
The UCSF Prostate Cancer Program announces an opportunity for pilot research funding in any area of investigation in prostate cancer. Funds are available to support multiple proposals. All areas of prostate cancer research including computational, laboratory, translational, clinical, and population sciences are eligible.
Foundations/Other Sources
- Deadline: July 10, 2026
DMG Accelerator RFA: Innovative Combination Therapy Approaches for Diffuse Intrinsic Pontine Glioma (DIPG) and Diffuse Midline Glioma (DMG)
On behalf of the DMG Accelerator, the PNOC Foundation invites applications for a new funding initiative to accelerate the development of innovative combination therapy approaches for DIPG and DMG. - Deadline: Sept 7, 2026
The Mike Slive Foundation for Prostate Cancer Research Pilot Research Grant
Guided by a commitment to find a cure for prostate cancer, this program funds pilot grants for innovative research to allow researchers to establish proof-of-concept when applying for larger, highly competitive federal grants. Research projects may focus on any topic related to the scientific study of prostate cancer, including but not limited to the prevention, diagnosis, treatment, or etiology of prostate cancer. The investigation of these topics may be basic, translational, behavioral, or clinical in nature.
NIH Announcements
If you are a Cancer Center member who is interested in applying and receiving grant writing support, please contact Erin Bank.
To view NCI funding opportunities, search here.
In accordance with Federal and State law and University policy, the University of California does not discriminate on the basis of age, gender, race, ethnicity, national origin, religion, sexual orientation, gender identity, health, or disability. For detailed information, please visit the Office for the Prevention of Harassment and Discrimination.